{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:29:32Z","timestamp":1789010972523,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.seminhematol.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T12:14:32Z","timestamp":1463487272000},"page":"203-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hodgkin lymphoma in the elderly, pregnant, and HIV-infected"],"prefix":"10.1053","volume":"53","author":[{"given":"Veronika","family":"Bachanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.seminhematol.2016.05.002_bib1","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/blood-2004-09-3759","article-title":"Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study","volume":"106","author":"Jarrett","year":"2005","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2016.05.002_bib2","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin\u2019s lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin\u2019s Study Group","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1 Suppl 1","key":"10.1053\/j.seminhematol.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1177\/030089160208800109","article-title":"Treatment of elderly Hodgkin\u2019s lymphoma patients. the experience of the Italian Lymphoma Intergroup","volume":"88","author":"Levis","year":"2002","journal-title":"Tumori"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.05.002_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib5","unstructured":"Johnson P, Federico M, Fossa A, et al. Response-adapted therapy based on interim FDG-PET scans in advanced Hodgkin lymphoma: first analysis of the safety of de-escalation and efficacy of escalation in the international RATHL study (CRUK\/07\/033). 13th International Conference on Malignant Lymphoma, Hematol Oncology Supplement 1. 2015;33:100-abstract 008."},{"issue":"18","key":"10.1053\/j.seminhematol.2016.05.002_bib6","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood-2015-11-681064","article-title":"Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials","volume":"127","author":"Boll","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/10428190500518602","article-title":"Hodgkin\u2019s lymphoma in the elderly: the results of 10 years of follow-up","volume":"47","author":"Feltl","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/10428190601126610","article-title":"Standard CHOP-21 as first line therapy for elderly patients with Hodgkin\u2019s lymphoma","volume":"48","author":"Kolstad","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/annonc\/mdi023","article-title":"A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin\u2019s disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)","volume":"16","author":"Ballova","year":"2005","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/10428190290033332","article-title":"Treatment of elderly Hodgkin\u2019s lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study","volume":"43","author":"Macpherson","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"10.1053\/j.seminhematol.2016.05.002_bib12","first-page":"2798","article-title":"A retrospective multicenter analysis of elderly Hodgkin lymphoma: Outcomes and prognostic factors in the modern era","volume":"126","author":"Evens","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oxfordjournals.annonc.a059112","volume":"6","year":"1995","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2016.05.002_bib14","first-page":"1087","article-title":"Hodgkin\u2019s disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen","volume":"20","author":"Weekes","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bjh.13904","article-title":"Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the fondazione italiana linfomi (FIL)","volume":"172","author":"Zallio","year":"2016","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1053\/j.seminhematol.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1182\/blood-2011-12-396556","article-title":"Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: The SHIELD study","volume":"119","author":"Proctor","year":"2012","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.seminhematol.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1182\/blood-2011-07-368167","article-title":"Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage\u00a0Hodgkin lymphoma","volume":"118","author":"B\u00f6ll","year":"2011","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.seminhematol.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2015-06-644336","article-title":"Phase 2 study of frontline brentuximab vedotin monotherapy in\u00a0Hodgkin lymphoma\u00a0patients aged 60 years and older","volume":"126","author":"Forero-Torres","year":"2015","journal-title":"Blood"},{"issue":"35","key":"10.1053\/j.seminhematol.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2013.49.8246","article-title":"Relapsed Hodgkin lymphoma in older patients: a comprehensive analysis from the German Hodgkin Study Group","volume":"31","author":"Boll","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminhematol.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3109\/10428194.2014.1001987","article-title":"High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma","volume":"56","author":"Martin","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1053\/j.seminhematol.2016.05.002_bib21","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.bbmt.2014.08.019","article-title":"Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma","volume":"20","author":"Dahi","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11899-013-0163-4","article-title":"Hodkin lymphoma in pregnancy","volume":"8","author":"Bachanova","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.05.002_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2967\/jnumed.109.071878","article-title":"Absorbed 18F-FDG dose to the fetus during early pregnancy","volume":"51","author":"Zanotti-Fregonara","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/asheducation-2008.1.334","article-title":"Challenging problems: coincident pregnancy, HIV infection, and older age","author":"Connors","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.05.002_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajh.21677","article-title":"Whole-body MRI for staging Hodgkin lymphoma in a pregnant patient","volume":"85","author":"Vermoolen","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.05.002_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1992.21","article-title":"Maternal and foetal outcome following Hodgkin\u2019s disease in pregnancy","volume":"65","author":"Lishner","year":"1992","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.05.002_bib27","first-page":"336","article-title":"Hodgkin\u2019s disease and pregnancy","volume":"69","author":"Gobbi","year":"1984","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.seminhematol.2016.05.002_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2015.63.3446","article-title":"Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma","volume":"34","author":"Weibull","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<304::AID-CNCR18>3.0.CO;2-#","article-title":"Pregnancy-associated lymphomas. A clinicopathologic study","volume":"78","author":"Gelb","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-61-108","article-title":"Vinblastine sulfate in Hodgkin\u2019s disease in pregnancy","volume":"61","author":"Rosenzweig","year":"1964","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000421-198604000-00009","article-title":"Management of coexisting Hodgkin\u2019s disease and pregnancy","volume":"9","author":"Nisce","year":"1986","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.05.002_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2257.2006.00781.x","article-title":"Hematological malignancy and pregnancy: a single-institution experience of 21 cases","volume":"28","author":"Dilek","year":"2006","journal-title":"Clin Lab Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","article-title":"Cytotoxic therapy and pregnancy","volume":"74","author":"Ebert","year":"1997","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000020898","article-title":"Hodgkin\u2019s disease during pregnancy: Diagnostic and therapeutic management","volume":"14","author":"Anselmo","year":"1999","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"10.1053\/j.seminhematol.2016.05.002_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-8545(05)70011-5","article-title":"Lymphoma and leukemia complicating pregnancy","volume":"25","author":"Peleg","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/QAI.0b013e31815e722b","article-title":"Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy","volume":"47","author":"Berenguer","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib37","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2014-08-551598","article-title":"How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus","volume":"125","author":"Uldrick","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2016.05.002_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with\u00a0HIV\u00a0in north america: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib39","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/annonc\/mdf239","article-title":"Hodgkin\u2019s disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony-stimulating factor","volume":"13","author":"Gastaldi","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00126334-200008150-00009","volume":"24","author":"Levine","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.05.002_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3816\/CLM.2007.n.014","article-title":"Hodgkin lymphoma among patients infected with HIV in post-HAART era","volume":"7","author":"Tanaka","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"10","key":"10.1053\/j.seminhematol.2016.05.002_bib42","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","article-title":"BEACOPP therapeutic regimen for patients with Hodgkin\u2019s disease and HIV infection","volume":"14","author":"Hartmann","year":"2003","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2016.05.002_bib43","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2016.05.002_bib44","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1080\/10428190701573216","article-title":"Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin\u2019s lymphoma","volume":"48","author":"Xicoy","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.seminhematol.2016.05.002_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cncr.29066","article-title":"Prognostic factors for advanced-stage human immunodeficiency virus-associated classical\u00a0Hodgkin lymphomatreated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study","volume":"121","author":"Castillo","year":"2015","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2016.05.002_bib46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cncr.29066","article-title":"Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study","volume":"121","author":"Castillo","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.05.002_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<57::AID-AJH13>3.0.CO;2-5","article-title":"Advanced Hodgkin\u2019s disease in a pregnant HIV seropositive woman: favorable mother and baby outcome following combined anticancer and antiretroviral therapy","volume":"63","author":"Klepfish","year":"2000","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1053\/j.seminhematol.2016.05.002_bib48","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/QAD.0000000000000851","article-title":"Postautologous stem cell transplantation long-term outcomes in 26 HIV-positive patients affected by relapsed\/refractory lymphoma","volume":"29","author":"Zanet","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"10.1053\/j.seminhematol.2016.05.002_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS malignancy consortium study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1053\/j.seminhematol.2016.05.002_bib50","first-page":"1100","article-title":"High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease","volume":"89","author":"Gabarre","year":"2004","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.05.002_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2015.62.4445","article-title":"Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting","volume":"34","author":"Lishner","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196316300397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:49Z","timestamp":1758522289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196316300397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0037196316300397"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.05.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hodgkin lymphoma in the elderly, pregnant, and HIV-infected","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}